We are live on
!
Find out more
DC
Decheng Capital Portfolio holdings
AUM
$661M
1-Year Est. Return
299.97%
This Fund
S&P 500
This Quarter
Est. Return
+28.86%
1 Year Est. Return
+299.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$661M
AUM Growth
-$82.1M
(-11%)
Cap. Flow
-$38M
Cap. Flow
% of AUM
-5.74%
Top 10 Holdings %
Top 10 Hldgs %
98.23%
Holding
19
New
–
Increased
–
Reduced
5
Closed
5
Top Buys
No buys this quarter
Top Sells
| 1 |
Revolution Medicines
RVMD
|
+$10.8M |
| 2 |
NewAmsterdam Pharma
NAMS
|
+$8.7M |
| 3 |
UPB
Upstream Bio Inc
UPB
|
+$7.52M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$4.32M |
| 5 |
Krystal Biotech
KRYS
|
+$2.66M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CG Oncology
CGON
$6.44B
| $431M | 65.21% |
6,371,669
| – | – |
|
2
Nuvation Bio
NUVB
$2.05B
| $111M | 16.84% |
25,954,439
| – | – |
|
|
UPB
3
Upstream Bio Inc
UPB
$396M
| $24.5M | 3.71% |
2,724,868
-418,210
| -13% | -$7.52M |
|
4
Aclaris Therapeutics
ACRS
$782M
| $15.2M | 2.29% |
4,041,736
| – | – |
|
|
AARD
5
Aardvark Therapeutics
AARD
$146M
| $14.8M | 2.23% |
3,917,299
| – | – |
|
6
Lyell Immunopharma
LYEL
$349M
| $13.9M | 2.1% |
692,050
| – | – |
|
|
7
NewAmsterdam Pharma
NAMS
$3.74B
| $10.4M | 1.57% |
325,057
-267,000
| -45% | -$8.7M |
|
8
Arcus Biosciences
RCUS
$3.52B
| $10.3M | 1.56% |
477,819
-63,740
| -12% | -$1.38M |
|
|
9
Revolution Medicines
RVMD
$39.2B
| $9.09M | 1.38% |
93,500
-106,500
| -53% | -$10.8M |
|
10
Equillium
EQ
$166M
| $8.89M | 1.35% |
4,447,308
| – | – |
|
11
BeyondSpring
BYSI
$52.2M
| $6.23M | 0.94% |
3,800,702
| – | – |
|
12
Zentalis Pharmaceuticals
ZNTL
$340M
| $3.1M | 0.47% |
1,323,327
| – | – |
|
|
13
Krystal Biotech
KRYS
$10.3B
| $1.89M | 0.29% |
7,300
-10,000
| -58% | -$2.66M |
|
14
Pyxis Oncology
PYXS
$154M
| $477K | 0.07% |
326,810
| – | – |
|
15
Aura Biosciences
AURA
$725M
| – | – |
-360,483
| Closed | -$1.96M |
|
|
16
Crinetics Pharmaceuticals
CRNX
$8.88B
| – | – |
-92,700
| Closed | -$4.32M |
|
17
4D Molecular Therapeutics
FDMT
$611M
| – | – |
-44,311
| Closed | -$332K |
|
|
NUVB.WS
18
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| – | – |
-646,057
| Closed | -$213K |
|
19
Rezolute
RZLT
$456M
| – | – |
-59,900
| Closed | -$141K |
|
Similar funds
TPM
AWA
FAM
OL
GC
HIG
RCG
AWM